Showing results (191-200 of 454) with videos related to
Sort By:
Pageof 46
The American Journal of Gastroenterology|June 1, 2011
Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleedingSalvador Augustin, José Altamirano, Antonio González, et al.Journal of Hepatology|January 5, 2005
Cardiac alterations in cirrhosis: reversibility after liver transplantationMireia Torregrosa, Santi Aguadé, Laura Dos, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 22, 2013
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis BRobert Perrillo, Maria Buti, Francois Durand, et al.Hepatology (Baltimore, Md.)|June 16, 2011
Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: meta-analyses of randomized, controlled trials and implications for the futureVincent Di Martino, Carine Richou, Jean-Paul Cervoni, et al.Gastroenterology|August 7, 2012
Predicted effects of treatment for HCV infection vary among European countriesSylvie Deuffic-Burban, Pierre Deltenre, Maria Buti, et al.Journal of Viral Hepatitis|February 24, 2026
Enhancing Chronic Hepatitis B and D Management Through a Tailored Mobile Health Application: Real-World Outcomes From the Adaptation of the NORA AppJudit Romero-Vico, Anna Feliu, Elena Vargas-Accarino, et al.Scientific Reports|June 18, 2017
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized miceKatja Giersch, Maria Homs, Tassilo Volz, et al.Journal of Hepatology|May 7, 2008
Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertensionMar Coll, Joan Genescà, Imma Raurell, et al.Medicine|February 17, 2017
Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work ProductivityZobair M Younossi, Maria Stepanova, Rafael Esteban, et al.Journal of Hepatology|April 10, 2014
Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE studyZobair M Younossi, Maria Stepanova, Stefan Zeuzem, et al.Pageof 46